Demise of the Milwaukee Protocol for Rabies

Alan C Jackson1

  • 1Department of Clinical Neurosciences (Neurology), Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Insights

The Milwaukee protocol for human rabies has not demonstrated efficacy in survivors, with numerous documented failures. New therapeutic strategies are needed to improve rabies survival rates and neurological outcomes.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Human rabies is nearly fatal, with few survivors often experiencing severe neurological deficits.
  • The Milwaukee protocol, involving induced coma and specific drugs, was proposed after a 2004 survivor but lacks evidence of efficacy.
  • Despite aggressive promotion, the protocol has seen at least 64 documented failures over two decades.

Purpose of the Study:

  • To evaluate the efficacy of the Milwaukee protocol in treating human rabies.
  • To critically assess the evidence supporting the Milwaukee protocol's use.
  • To advocate for the abandonment of the Milwaukee protocol and the exploration of novel therapeutic approaches.

Main Methods:

  • Review of documented cases of rabies treated with the Milwaukee protocol.
  • Analysis of survival rates and neurological sequelae in patients receiving the protocol.
  • Comparison of outcomes with historical data and critical care management.

Main Results:

  • No subsequent detailed reports have confirmed the efficacy of the Milwaukee protocol since its inception.
  • At least 64 cases have documented the failure of the Milwaukee protocol.
  • Critical care management, used for decades, is a likely contributor to survival, not the protocol itself.

Conclusions:

  • The Milwaukee protocol has failed to demonstrate consistent efficacy in treating human rabies.
  • Continued use of the Milwaukee protocol is not supported by scientific evidence.
  • New therapeutic strategies informed by rabies pathogenesis are urgently required to improve patient outcomes.